Jasper Therapeutics, Inc. Share Price & Technical Analysis
JSPR · $0.88 (-8.33%)
Healthcare / Biotechnology
$0.88
-8.33%
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factors from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercia…
Price chart
Seasonality
May has 3 positive and 0 negative years (last 5 years shown)
0% return in May, 8% avg return in past 3 year May month.
-54% return in 2026, -14% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -17% | -7% | -31% | 0% | 0% | – | – | – | – | – | – | – | -54% |
| 25 | -72% | 0% | -28% | 28% | 0% | 0% | -48% | 0% | -14% | -4% | -22% | 0% | -160% |
| 24 | 74% | 80% | 37% | -22% | 7% | -13% | -18% | 18% | -14% | 15% | 7% | -9% | 163% |
| 23 | 13% | 8% | -6% | -27% | 17% | -10% | 12% | -17% | -42% | -10% | -11% | 27% | -45% |
| 22 | -39% | -21% | -4% | -13% | 1% | -39% | -1% | -4% | -58% | -6% | -17% | -24% | -226% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Neutral
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factors from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma. Jasper Therapeutics, Inc. was founded in 2018 and is headquartered in Redwood City, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$25.51M
P/E ratio
—
52W high
$7.19
52W low
$0.62
Volume
8,781
Beta
3.08
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Jasper Therapeutics, Inc. share price today?
- Jasper Therapeutics, Inc. (JSPR) last traded around $0.88 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does JSPR have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for JSPR. Download the app for real-time alerts.
- How can I analyze Jasper Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.